Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, 635 Charles E. Young Dr. South, Neuroscience Research Building, Rm 415, Los Angeles, CA, 90095, USA.
Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, 90095, USA.
Transl Stroke Res. 2020 Oct;11(5):1064-1076. doi: 10.1007/s12975-020-00786-0. Epub 2020 Feb 21.
Subcortical white matter ischemic lesions are increasingly recognized to have pathologic overlap in individuals with Alzheimer's disease (AD). The interaction of white matter ischemic lesions with amyloid pathology seen in AD is poorly characterized. We designed a novel mouse model of subcortical white matter ischemic stroke and AD that can inform our understanding of the cellular and molecular mechanisms of mixed vascular and AD dementia. Subcortical white matter ischemic stroke underlying forelimb motor cortex was induced by local stereotactic injection of an irreversible eNOS inhibitor. Subcortical white matter ischemic stroke or sham procedures were performed on human ApoE4-targeted-replacement (TR):5XFAD mice at 8 weeks of age. Behavioral tests were done at 7, 10, 15, and 20 weeks. A subset of animals underwent FDG-PET/CT. At 20 weeks of age, brain tissue was examined for amyloid plaque accumulation and cellular changes. Compared with sham E4-TR:5XFAD mice, those with an early subcortical ischemic stroke showed a significant reduction in amyloid plaque burden in the region of cortex overlying the subcortical stroke. Cognitive performance was improved in E4-TR:5XFAD mice with stroke compared with sham E4-TR:5XFAD animals. Iba-1+ microglial cells in the region of cortex overlying the subcortical stroke were increased in number and morphologic complexity compared with sham E4-TR:5XFAD mice, suggesting that amyloid clearance may be promoted by an interaction between activated microglia and cortical neurons in response to subcortical stroke. This novel approach to modeling mixed vascular and AD dementia provides a valuable tool for dissecting the molecular interactions between these two common pathologies.
皮质下白质缺血性病变在阿尔茨海默病(AD)患者中越来越被认为具有病理学重叠。AD 中皮质下白质缺血性病变与淀粉样蛋白病理学的相互作用尚未得到充分描述。我们设计了一种新的皮质下白质缺血性中风和 AD 的小鼠模型,可帮助我们了解混合血管性和 AD 痴呆的细胞和分子机制。通过局部立体定向注射不可逆的 eNOS 抑制剂诱导前肢运动皮层下皮质下白质缺血性中风。在 8 周龄时,对皮质下白质缺血性中风或假手术处理的人类 ApoE4 靶向置换(TR):5XFAD 小鼠进行皮质下白质缺血性中风或假手术处理。在 7、10、15 和 20 周时进行行为测试。部分动物进行了 FDG-PET/CT。在 20 周龄时,检查脑组织中淀粉样斑块的积累和细胞变化。与假手术 E4-TR:5XFAD 小鼠相比,早期皮质下缺血性中风的小鼠在皮质下中风区域的淀粉样斑块负担明显减少。与假手术 E4-TR:5XFAD 动物相比,中风的 E4-TR:5XFAD 小鼠的认知表现得到改善。与假手术 E4-TR:5XFAD 小鼠相比,皮质下中风区域的 Iba-1+小胶质细胞数量和形态复杂性增加,提示皮质下中风后,激活的小胶质细胞与皮质神经元之间的相互作用可能促进淀粉样蛋白清除。这种新的混合血管性和 AD 痴呆建模方法为剖析这两种常见病理之间的分子相互作用提供了有价值的工具。